companiesSEC EDGAR
Acrivon Therapeutics, Inc.

SEC EDGAR published this disclosure on 2026-08-12. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001193125-26-346819
cik1781174
company nameAcrivon Therapeutics, Inc.
form10-Q